Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 23 for “"LUSC"”.
-
Dissecting the Anti-Tumour Role of Interleukin (IL)-36 in Lung Squamous Cell Carcinoma
Lung squamous cell carcinoma (LUSC) is a prevalent subtype of non-small cell lung cancer. Due to poor understanding of disease mechanisms, treatment options remain limited. Recent studies suggest potential anti-tumour role for interleukin (IL)-36 cytokines. However, the underlying mechanisms remain …
-
SMAD4 loss promotes lung squamous cell carcinoma progression by remodelling 3D genome
… understood. Lung squamous cell carcinoma (LUSC), a malignancy currently lacking effective targeted therapies, was employed as a disease model to investigate the role of 3D chromatin remodeling in tumorigenesis. A deeper understanding of the regulatory mechanisms governing chromatin …
-
O uso de redes neurais artificiais na análise de dados de câncer de pulmão
… Genome Atlas) databases were obtained for the LUSC (Lung Squamous Cell Carcinoma) and LUAD (Lung Adenocarcinoma) cohorts, followed by the analysis of the genomic alterations, and application of neural networks using as input the frequently mutated genes for each cohort, selection of key genes …
-
Análise de bioinformática e aprendizado de máquina na busca por biomarcadores em carcinoma de células escamosas de pulmão
… lung cancer types, Lung Squamous Cell Carcinoma (LUSC) is the second most common type, frequently diagnosed in advanced stages, poor prognosis, and high association with smoking. Due to the severity of lung cancer, it is essential to understand its molecular mechanisms. In this context, this study …
-
Somatic genome alterations in relation to age in smoking related cancers
… Carcinoma (HNSCC), Lung Squamous Cell Carcinoma (LUSC) and Lung Adenocarcinoma (LUAD) are among the most common cause of global cancer-related mortality and the common major risk factor is smoking consumption. By analyzing 203 HNSCC, 480 LUSC and 486 LUAD samples from The Cancer Genome Atlas, we …
-
Deep learning applications for differential diagnosis of lung cancer : the effect of spatial resolution on classification of histopathology images
… (LUAD) = 823, squamous-cell carcinoma (LUSC) = 753, and normal = 591) were used to train (70%) and test (30%) a convolutional neural network (Inception-v3) as a binary (cancer vs. normal) and three-way classifier (LUAD vs. LUSC vs. normal). Slides were partitioned into tiles at …
-
INVESTIGATING PLASMA MICRORNA AND PROTEIN MARKERS FOR EARLY DETECTION OF LUNG CANCER
… (LUAD), 30 with lung squamous cell carcinoma (LUSC), and 31 with NNLD. Candidate miRNA and protein marker abundances were quantitated. The results were tested for associations with clinicopathological variables and used to develop a FIS classifier. Model performance was evaluated using an …
-
Proteogenomische Multiplexanalyse für die Tumordiagnostik
… von primären Plattenepithelkarzinomen der Lunge (LUSC) zu unterscheiden. Beide ähneln sich histomorphologisch und treten häufig bei Patienten mit HNSC auf. Zur Unterscheidung der DNA-Methylierungsprofile beider Tumortypen wurden drei maschinelle Lernverfahren eingesetzt. In einer unabhängigen …
-
Modeling premalignant lung squamous carcinoma via gene expression changes associated with EP300 knockout
… diagnosis. While lung squamous cell carcinoma (LUSC) makes up 20-30% of all lung cancer cases, identification of genetic signatures and successful targeted therapies remain limited. An ongoing effort is being made to create an in vitro system for modeling the early stages of lung squamous …
-
Liquid Biopsy in non-small cell lung cancer: exosomes as a tool for the study of biomarkers.
… adenocarcinoma (LUAD) y carcinoma escamoso (LUSC). Posteriormente, para validar los hallazgos obtenidos en exosomas, los marcadores más significativos fueron analizados in silico en una cohorte de muestras de tejido, compuesta por 661 pacientes con CPNM (TCGA database). Estos resultados han …
-
Deciphering the immune contexture of premalignancy in a murine model of lung squamous cell carcinoma
… PMLs that precede lung squamous cell carcinoma (LUSC), the second most common LC subtype accounting for 20-30% of LC cases, arise within the airway field of injury caused by smoking. Our group and others have established focused efforts defining the molecular alterations that drive progression of …
-
The Role of the Microbiota in the Carcinogenesis and Progression of Squamous Cell Carcinoma: A Multi-Omic Investigation of Oral and Lung Tumours
… tract, including Lung Squamous Cell Carcinoma (LUSC) and Head and Neck Squamous Cell Carcinoma (HNSCC), share common etiological risk factors, anatomical continuity, and biological features. While genetic and environmental drivers are well established, increasing evidence suggests that the …
-
Preclinical Modeling of Driver Alterations in Non-small Cell Lung Cancer
… in PIK3CA mutant lung squamous cell carcinoma (LUSC). In the third study, I have developed a protocol for culturing NSCLC organoids and identified FGFR1 and MEK inhibitor combination as a potential therapeutic strategy in FGFR1 amplified LUSC. The findings outlined in this dissertation will not …
-
Deep Learning for Histopathology Whole Slide Image Analysis
… on three public datasets, namely TCGA-GBM, TCGA-LUSC and NLST, confirms the framework's efficacy and its state-of-the-art performance. The second study tackles intra-domain variability among WSIs by developing a model that efficiently translates FF slides into FFPE-style slides. It leverages the …
-
Investigation of KimiaNet's and DenseNet's deep features in lung cancer subtypes
… (LUAD) or lung squamous carcinoma (LUSC). A deep feature-specific visualization technique was proposed for analyzing deep features at WSI-level. These prominent deep features were also generalizable to cancers of other organs, namely kidney and brain. However, deep features did not …
-
Establishing the consequences of NOTCH1 modulation, by small molecule inhibitors, on epithelium growth and differentiation
… annually, with lung squamous cell carcinoma (LUSC) being heavily associated with smokers. Prognosis declines with the stage of lung cancer at diagnosis, with stage IA patients having a 50% 5-year survival rate and patients diagnosed with stage IIIA lung cancer having only a 19% 5-year …
-
Identifying mutational landscape and inflammatory pathways associated with lung squamous premalignant lesion progression
… cancer known as lung squamous cell carcinoma (LUSC) is the second most predominant subtype accounting for ~30% of all lung cancer cases. Lung cancer is typically diagnosed at advanced stages, resulting in poor prognosis with a 5-year survival rate of 19% between 2008 and 2014 (Siegel et al., …
-
Identification of immune-related gene signatures to evaluate immunotherapeutic response in cancer patients using exploratory subgroup discovery
… Adenocarcinoma (LUAD), Lung Squamous Carcinoma (LUSC), Skin Cutaneous Melanoma (SKCM) and Triple-Negative Breast Cancer (TNBC). We employ various regression models to identify immune-related gene signatures and drug targets that increase the likelihood of partial remission on combination …
-
Investigating the role of developmental programmes in lung adenocarcinoma progression
… (LUAD) but not in lung squamous cell carcinomas (LUSC). Next, to understand the transcriptomic changes at the single cell level as well as to identify potential cell types that could regulate BM expression in cancer, cell-type specific gene co-expression modules were identified in epithelial and …
-
Uncertainty estimation of weakly supervised predictive models for out-of-distribution detection in digital pathology
… between LUAD (lung adenocarcinoma) and LUSC (lung squamous cell carcinoma) as in-distribution classes, while also differentiating NSCLC as in-distribution from Lower Grade Glioma (LGG) as out-of-distribution. Our top-performing model, M-Branch, efficiently estimates predictive …
Page 1 of 2